COVID‐19 drug repurposing: A review of computational screening methods, clinical trials, and protein interaction assays
Author:
Affiliation:
1. Department of Computational Medicine and Bioinformatics, Michigan Medicine University of Michigan Ann Arbor Michigan USA
2. Department of Internal Medicine University of Michigan Ann Arbor Michigan USA
Publisher
Wiley
Subject
Drug Discovery,Pharmacology,Molecular Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/med.21728
Reference96 articles.
1. Overview of lethal human coronaviruses
2. Drug Repurposing for Viral Infectious Diseases: How Far Are We?
3. Compassionate Use of Remdesivir for Patients with Severe Covid-19
4. Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status
Cited by 77 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Identification of Potential Inhibitors of SARS-CoV-2 Using Machine Learning, Molecular Docking and MD Simulation;2024-08-20
2. Design and Synthesis of Red-Absorbing Fluoran Leuco Dyes Supported by Computational Screening;ACS Omega;2024-08-02
3. Evaluation of infliximab-induced genotoxicity and possible action on BCL-2 and P53 genes;Journal of Toxicology and Environmental Health, Part A;2024-06-26
4. Effectiveness of dolutegravir in moderate severity COVID-19 patients: A single-center, randomized, double-blind, placebo-controlled trial;BioImpacts;2024-06-26
5. Identification of Potential Inhibitors of SARS-CoV-2 Using Machine Learning, Molecular Docking and MD Simulation;2024-05-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3